Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elena I, Anisimova"'
Autor:
Aglaya G. Iyevleva, Svetlana N. Aleksakhina, Anna P. Sokolenko, Sofia V. Baskina, Aigul R. Venina, Elena I. Anisimova, Ilya V. Bizin, Alexandr O. Ivantsov, Yana V. Belysheva, Alexandra P. Chernyakova, Alexandr V. Togo, Evgeny N. Imyanitov
Publikováno v:
Breast Cancer Research and Treatment. 192:283-291
Autor:
Ilya V. Bizin, Alexandr A. Bessonov, Mikhail A Maydin, Aldon J. Whitehead, Olga A Volynshchikova, Albina A Avanesyan, Elena I Anisimova, Valeria I. Ni, Alexandr M Scherbakov, Alexandr A. Romanko, Evgeny N. Imyanitov, Oleg B Tkachenko, Grigory A. Raskin, Alexandr O. Ivantsov, Maxim A Kleshchev, Tatiana V. Gorodnova, Ksenia Shelekhova, Robert V Broyde, Anna P. Sokolenko
Publikováno v:
Pathobiology. 87:367-374
Introduction: There is some evidence suggesting a link between BRCA1/2 germline mutations and increased risk of gastric cancer. Methods: Endoscopic screening for stomach malignancies was performed in 120 BRCA1 mutation carriers in order to evaluate t
Autor:
Aglaya G, Iyevleva, Svetlana N, Aleksakhina, Anna P, Sokolenko, Sofia V, Baskina, Aigul R, Venina, Elena I, Anisimova, Ilya V, Bizin, Alexandr O, Ivantsov, Yana V, Belysheva, Alexandra P, Chernyakova, Alexandr V, Togo, Evgeny N, Imyanitov
Publikováno v:
Breast cancer research and treatment. 192(2)
Germline mutations in CHEK2 gene represent the second most frequent cause of hereditary breast cancer (BC) after BRCA1/2 lesions. This study aimed to identify the molecular characteristics of CHEK2-driven BCs.Loss of heterozygosity (LOH) for the rema
Autor:
Evgeny N. Suspitsin, Peter Schürmann, Ilya V. Bizin, Maria O. Anisimova, Darya Prokofyeva, Aigul R. Venina, Elza Khusnutdinova, Tatiana N. Sokolova, Natalia Bogdanova, Ashok K. Varma, Evgeny N. Imyanitov, Maria A. Mantseva, Ekaterina Sh Kuligina, Andrey V. Koloskov, Syed K. Hasan, Ana Marija Milanović, Svetlana N. Aleksakhina, Anna P. Sokolenko, Marina Bermisheva, Daria D. Krylova, Kirill A. Zagorodnev, Thilo Dörk, Valeria I. Ni, Alexandr A. Romanko, Elena I Anisimova
Publikováno v:
Breast Cancer Research and Treatment. 179:731-742
Germline variants in known breast cancer (BC) predisposing genes explain less than half of hereditary BC cases. This study aimed to identify missing genetic determinants of BC. Whole exome sequencing (WES) of lymphocyte DNA was performed for 49 Russi
Autor:
Alexandr O. Ivantsov, Anna P. Sokolenko, Elena V. Preobrazhenskaya, Alexandr S. Martianov, Svetlana A Chuinyshena, Olga A. Gorustovich, Alla U Shleykina, Tatjana N Sokolova, Alexandr V. Togo, Ekatherina Sh. Kuligina, Ilya V. Bizin, Elena I Anisimova, Evgeny N. Imyanitov, Alexey M. Belyaev
Publikováno v:
International journal of cancerREFERENCES. 148(1)
PALB2 is а high-penetrance gene for hereditary breast cancer (BC). Our study aimed to investigate the spectrum of PALB2 mutations in Russian cancer patients. PALB2 sequencing revealed pathogenic variants in 3/190 (1.6%) young-onset and/or familial a
Autor:
Elena I Anisimova, Ilya V. Bizin, Anna P. Sokolenko, Alexey M. Belyaev, Alexandr A. Bessonov, Svetlana N. Aleksakhina, Elena L. Savonevich, Tatiana N. Sokolova, Tatiana V. Gorodnova, Elena V. Preobrazhenskaya, Ilya A. Stepanov, Petr Krivorotko, Aglaya G. Iyevleva, Valeria I. Ni, Alexandr V. Togo, Evgeny N. Imyanitov, Alexandr A. Romanko, Igor Berlev
Publikováno v:
Breast cancer research and treatment. 184(1)
The spectrum of BRCA1 and BRCA2 mutations in Slavic countries is characterized by a high prevalence of founder alleles. We analyzed a large data set of Russian breast cancer (BC) and ovarian cancer (OC) patients, who were subjected to founder mutatio
Autor:
Albina A, Avanesyan, Anna P, Sokolenko, Alexandr O, Ivantsov, Maxim A, Kleshchev, Mikhail A, Maydin, Ilya V, Bizin, Grigory A, Raskin, Ksenia V, Shelekhova, Tatiana V, Gorodnova, Alexandr A, Bessonov, Elena I, Anisimova, Olga A, Volynshchikova, Alexandr A, Romanko, Valeria I, Ni, Robert V, Broyde, Oleg B, Tkachenko, Aldon J, Whitehead, Alexandr M, Scherbakov, Evgeny N, Imyanitov
Publikováno v:
Pathobiology : journal of immunopathology, molecular and cellular biology. 87(6)
There is some evidence suggesting a link between BRCA1/2 germline mutations and increased risk of gastric cancer.Endoscopic screening for stomach malignancies was performed in 120 BRCA1 mutation carriers in order to evaluate the probability of detect
Autor:
Ekatherina Sh. Kuligina, Tatiana V. Gorodnova, Evgeny N. Imyanitov, Alla Yu Shleykina, Elena I Anisimova, Alexey M. Belyaev, Evgeny N. Suspitsin, Anna P. Sokolenko, Olga A Zaytseva, Ilya V. Bizin, Elena V. Preobrazhenskaya, Sergey A. Laptiev
Publikováno v:
Breast cancer research and treatment. 165(3)
Large genomic rearrangements (LGRs) constitute a significant share of pathogenic BRCA1 mutations. Multiplex ligation-dependent probe amplification (MLPA) is a leading method for LGR detection; however, it is entirely based on the use of commercial ki